Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics
Crossref DOI link: https://doi.org/10.1007/s10856-016-5800-8
Published Online: 2016-10-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stiel, Norbert
Hissnauer, Tim N.
Rupprecht, Martin
Babin, Kornelia
Schlickewei, Carsten W.
Rueger, Johannes M.
Stuecker, Ralf
Spiro, Alexander S.
License valid from 2016-10-27